Cargando…
Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection”
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Microbiology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858077/ https://www.ncbi.nlm.nih.gov/pubmed/33531392 http://dx.doi.org/10.1128/mBio.03682-20 |
| _version_ | 1783646577632477184 |
|---|---|
| author | Gold, Jeffrey E. Hurley, David J. Rada, Balázs Baumgartl, William H. Tilley, Larry P. Licht, Warren E. |
| author_facet | Gold, Jeffrey E. Hurley, David J. Rada, Balázs Baumgartl, William H. Tilley, Larry P. Licht, Warren E. |
| author_sort | Gold, Jeffrey E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7858077 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Society for Microbiology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78580772021-02-05 Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection” Gold, Jeffrey E. Hurley, David J. Rada, Balázs Baumgartl, William H. Tilley, Larry P. Licht, Warren E. mBio Author Reply American Society for Microbiology 2021-02-02 /pmc/articles/PMC7858077/ /pubmed/33531392 http://dx.doi.org/10.1128/mBio.03682-20 Text en Copyright © 2021 Gold et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Reply Gold, Jeffrey E. Hurley, David J. Rada, Balázs Baumgartl, William H. Tilley, Larry P. Licht, Warren E. Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection” |
| title | Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection” |
| title_full | Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection” |
| title_fullStr | Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection” |
| title_full_unstemmed | Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection” |
| title_short | Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection” |
| title_sort | reply to marakasova and baranova, “mmr vaccine and covid-19: measles protein homology may contribute to cross-reactivity or to complement activation protection” |
| topic | Author Reply |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858077/ https://www.ncbi.nlm.nih.gov/pubmed/33531392 http://dx.doi.org/10.1128/mBio.03682-20 |
| work_keys_str_mv | AT goldjeffreye replytomarakasovaandbaranovammrvaccineandcovid19measlesproteinhomologymaycontributetocrossreactivityortocomplementactivationprotection AT hurleydavidj replytomarakasovaandbaranovammrvaccineandcovid19measlesproteinhomologymaycontributetocrossreactivityortocomplementactivationprotection AT radabalazs replytomarakasovaandbaranovammrvaccineandcovid19measlesproteinhomologymaycontributetocrossreactivityortocomplementactivationprotection AT baumgartlwilliamh replytomarakasovaandbaranovammrvaccineandcovid19measlesproteinhomologymaycontributetocrossreactivityortocomplementactivationprotection AT tilleylarryp replytomarakasovaandbaranovammrvaccineandcovid19measlesproteinhomologymaycontributetocrossreactivityortocomplementactivationprotection AT lichtwarrene replytomarakasovaandbaranovammrvaccineandcovid19measlesproteinhomologymaycontributetocrossreactivityortocomplementactivationprotection |